Proteomic Diagnosis Models from Serum for Early Detection of Oral Squamous Cell Carcinoma

被引:8
作者
Sun, Gang [1 ]
He, Hong [1 ]
Ping, Feiyun [1 ]
Zhang, Feifei [1 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Stomatol, Hangzhou 310009, Zhejiang, Peoples R China
来源
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY | 2009年 / 37卷 / 03期
关键词
Serum; bio-informatics; leave-one-out; discriminant analysis; support vector machines; oral squamous cell carcinoma (OSCC); SELDI-TOF-MS (surface enhanced laser desorption; ionization-time of flight-mass spectrometry); protein chip M10; proteome; mass; charge; IDENTIFICATION;
D O I
10.1080/10731190902913759
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The early diagnosis of oral squamous cell carcinoma (OSCC) is crucial to prevent deformity and malfunction post-surgery, as well as to allow clinicians to make a rapid decision about treatment. The aim of this study was to search a serum diagnostic model at a molecular level for OSCC. After collection and processing of serum from 28 OSCC patients and 32 healthy volunteers in the Department of Stomatology at the university hospital, samples were detected using Surface Enhanced Laser Desorption Ionization Time of Flight Mass Spectrometry (SELDI-TOF-MS) technology with CM10 protein chip and bioinformatics. Seven protein mass peaks were screened out to build a serum diagnosis model with a significant P value, respectively, and the sensitivity, specificity, and total accuracy were 93.75%, 92.86%, and 93.33%. The use of serum protein fingerprint provides a promising approach for early diagnostics, which could benefit determining preventative and therapeutic stages of patients with OSCC.
引用
收藏
页码:125 / 129
页数:5
相关论文
共 9 条
[1]   Molecular assay to detect metastatic head and neck squamous cell carcinoma [J].
Becker, MT ;
Shores, CG ;
Yu, KK ;
Yarbrough, WG .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2004, 130 (01) :21-27
[2]   The incidence of lymph node micrometastases in patients pathologically staged N0 in cancer of oral cavity and oropharynx [J].
Ferlito, A ;
Shaha, AR ;
Rinaldo, A .
ORAL ONCOLOGY, 2002, 38 (01) :3-5
[3]   The SELDI-TOF MS approach to proteomics: Protein profiling and biomarker identification [J].
Issaq, HJ ;
Veenstra, TD ;
Conrads, TP ;
Felschow, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 292 (03) :587-592
[4]  
Merchant M, 2000, ELECTROPHORESIS, V21, P1164, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1164::AID-ELPS1164>3.3.CO
[5]  
2-S
[6]  
Németh Z, 2005, NEOPLASMA, V52, P95
[7]   Proteomics strategies for protein identification [J].
Resing, KA ;
Ahn, NG .
FEBS LETTERS, 2005, 579 (04) :885-889
[8]  
Weinberger S R, 2000, Pharmacogenomics, V1, P395, DOI 10.1517/14622416.1.4.395
[9]   Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients. [J].
Xu W.H. ;
Chen Y.D. ;
Hu Y. ;
Yu J.K. ;
Wu X.G. ;
Jiang T.J. ;
Zheng S. ;
Zhang S.Z. .
Journal of Zhejiang University SCIENCE B, 2006, 7 (3) :235-240